BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:rusfertide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of rusfertide\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07648030-10912@assetmemo.bio
DTSTAMP:20261121T004530Z
DTSTART;VALUE=DATE:20271028
DTEND;VALUE=DATE:20271029
SUMMARY:rusfertide: Phase 2 readout est. (NCT07648030)
DESCRIPTION:rusfertide\, phase 2\, Polycythemia Vera.\nStudy: A Study of Ru
 sfertide in Japanese Adults With Polycythemia Vera\nEstimated primary comp
 letion: 28 October 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/rusfertide#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07648030
URL:https://assetmemo.bio/drug/rusfertide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07765602-10912@assetmemo.bio
DTSTAMP:20261121T004530Z
DTSTART;VALUE=DATE:20280701
DTEND;VALUE=DATE:20280702
SUMMARY:rusfertide: Phase 2 readout est. (NCT07765602)
DESCRIPTION:rusfertide\, phase 2\, Polycythemia Vera.\nStudy: A Study of Ru
 sfertide in Adults With Polycythemia Vera in China\nEstimated primary comp
 letion: 1 July 2028. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 rusfertide#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT07765602
URL:https://assetmemo.bio/drug/rusfertide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
